US Health & Fitness
Regulatory pressure is mounting on Amgen’s inflammatory disorder drug, Tavneos, with the European Medicines Agency recommending revocation of the product’s approval in its territory.…
Healthcare has made real progress on interoperability, but we are still solving the wrong problem.…
Now that the federal government has finalized the rule allowing non-network plans onto the ACA…
Fewer than one in ten smokers who try to quit each year succeed. That number…
A new report from the Office of Inspector General revealed that the three largest Medicare…
Amgen is standing behind a rare disease drug that the FDA wants off the market…
Healthcare is in the middle of an AI gold rush, with investors, providers and payers…
